In addition, it has been shown in prostate cancer, that the inhibition of PAX2 resulted in cell death independent of p53, demonstrating that additional tumor supressors or cell death pathways are inhibited by PAX2 in prostate cancer. Here, TP53 is linked to prostate cancer.